• 2025
  Alonso R, Garcia Z, Corre B, Lemaître F, Vaganay C, Saklani H, Grandjean CL, Yatim N, Bousso P, Reprogramming RIPK3-induced cell death in malignant B cells promotes immune-mediated tumor control., Sci Adv 2025 Aug; 11(33): eadv0871.
• 2024
  Ruggiu M, Guérin MV, Corre B, Bardou M, Alonso R, Russo E, Garcia Z, Feldmann L, Lemaître F, Dusseaux M, Grandjean CL, Bousso P, Anti-PD-1 therapy triggers Tfh cell-dependent IL-4 release to boost CD8 T cell responses in tumor-draining lymph nodes., J Exp Med 2024 Apr; 221(4): .
• 2023
  Morgane Boulch, Marine Cazaux, Alexis Cuffel, Mathilde Ruggiu, Vincent Allain, Béatrice Corre, Yann Loe-Mie, Benoit Hosten, Salvatore Cisternino, Sylvain Auvity, Catherine Thieblemont, Sophie Caillat-Zucman, Philippe Bousso, A major role for CD4+ T cells in driving cytokine release syndrome during CAR T cell therapy, Cell Reports Medicine, 2023, 4 (9), pp.101161. ⟨10.1016/j.xcrm.2023.101161⟩.
• 2023
  Boulch M, Cazaux M, Cuffel A, Guerin MV, Garcia Z, Alonso R, Lemaître F, Beer A, Corre B, Menger L, Grandjean CL, Morin F, Thieblemont C, Caillat-Zucman S, Bousso P, Tumor-intrinsic sensitivity to the pro-apoptotic effects of IFN-γ is a major determinant of CD4+ CAR T-cell antitumor activity., Nat Cancer 2023 Jul; 4(7): 968-983.
• 2023
  Corre B, El Janati Elidrissi Y, Duval J, Quilhot M, Lefebvre G, Ecomard S, Lemaître F, Garcia Z, Bohineust A, Russo E, Bousso P, Integration of intermittent calcium signals in T cells revealed by temporally patterned optogenetics., iScience 2023 Feb; 26(2): 106068.
• 2022
  Russo E, Lemaître F, Corre B, Chikina AS, Langa-Vives F, Bousso P, , SPICE-Met: profiling and imaging energy metabolism at the single-cell level using a fluorescent reporter mouse., EMBO J 2022 Aug; (): e111528.
• 2022
  Khazen R, Corre B, Garcia Z, Lemaître F, Bachellier-Bassi S, d'Enfert C, Bousso P, , Spatiotemporal dynamics of calcium signals during neutrophil cluster formation., Proc Natl Acad Sci U S A 2022 Jul; 119(29): e2203855119.
• 2021
  Khazen R, Cazaux M, Lemaître F, Corre B, Garcia Z, Bousso P, , Functional heterogeneity of cytotoxic T cells and tumor resistance to cytotoxic hits limit anti-tumor activity in vivo., EMBO J 2021 Apr; (): e106658.
• 2021
  Boulch M, Cazaux M, Loe-Mie Y, Thibaut R, Corre B, Lemaître F, Grandjean CL, Garcia Z, Bousso P, , A cross-talk between CAR T cell subsets and the tumor microenvironment is essential for sustained cytotoxic activity., Sci Immunol 2021 Mar; 6(57): .
• 2021
  Devi-Marulkar P, Moraes-Cabe C, Campagne P, Corre B, Meghraoui-Kheddar A, Bondet V, Llibre A, Duffy D, Maillart E, Papeix C, Pellegrini S, Michel F, , Altered Immune Phenotypes and HLA-DQB1 Gene Variation in Multiple Sclerosis Patients Failing Interferon β Treatment., Front Immunol 2021 ; 12(): 628375.
• 2017
  Govender U, Corre B, Bourdache Y, Pellegrini S, Michel F, Type I interferon-enhanced IL-10 expression in human CD4 T cells is regulated by STAT3, STAT2, and BATF transcription factors, J. Leukoc. Biol. 2017 05;101(5):1181-1190.